15 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $3.3B | -$1.1B | 0.0% | 0.0% | -$440M | $2.5B | $133M |
| 2024 | $3.2B | $256M | 0.0% | 0.0% | -$561M | $2.0B | $76M |
| 2023 | $2.9B | -$22M | 0.0% | 0.0% | $38M | $1.4B | $100M |
| 2022 | $2.6B | $273M | 0.0% | 0.0% | $84M | $1.4B | $98M |
| 2021 | $2.3B | $191M | 0.0% | 0.0% | $130M | $1.5B | $134M |
| 2020 | $2.1B | -$672M | 0.0% | 0.0% | $434M | $3.1B | $379M |
| 2019 | $2.0B | $109M | 0.0% | 29.2% | $100M | $3.1B | $100M |
| 2018 | $1.9B | -$176M | 0.0% | 31.2% | $161M | $3.2B | $51M |
| 2017 | $2.8B | $200M | 0.0% | 21.3% | $125M | $3.2B | $67M |
| 2016 | $2.8B | $6M | 0.0% | 21.7% | $54M | $3.3B | $57M |
| 2015 | — | $113M | — | — | -$36M | $2.2B | $11M |
| 2014 | — | $83M | — | — | $2M | $1.1B | $94M |
| 2013 | — | $43M | — | — | -$3M | $617M | $5M |
| 2012 | — | $20M | — | — | $6M | $473M | $49M |
| 2011 | — | -$35M | — | — | -$30M | $277M | $61M |
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '26 | $829M | $4M | 0.0% | 0.0% | -$15M | $2.5B | $158M |
| Dec '25 | $821M | -$1.2B | 0.0% | 0.0% | -$179M | $2.5B | $133M |
| Sep '25 | $852M | $36M | 0.0% | 0.0% | -$63M | $2.3B | $119M |
| Jun '25 | $869M | $30M | 0.0% | 0.0% | -$34M | $2.3B | $131M |
| Mar '25 | $771M | $8M | 0.0% | 0.0% | -$163M | $2.2B | $91M |
| Dec '24 | $774M | $33M | 0.0% | 0.0% | -$87M | $2.0B | $76M |
| Sep '24 | $816M | $68M | 0.0% | 0.0% | -$27M | $1.9B | $82M |
| Jun '24 | $796M | $78M | 0.0% | 0.0% | $17M | $1.8B | $77M |
| Mar '24 | $768M | $76M | 0.0% | 0.0% | -$464M | $1.9B | $77M |
| Dec '23 | $743M | $58M | 0.0% | 0.0% | -$22M | $1.4B | $100M |
| Sep '23 | $750M | -$218M | 0.0% | 0.0% | $10M | $1.4B | $100M |
| Jun '23 | $731M | $72M | 0.0% | 0.0% | $73M | $1.4B | $112M |
| Mar '23 | $704M | $66M | 0.0% | 0.0% | -$22M | $1.4B | $64M |
| Dec '22 | $675M | $61M | 0.0% | 0.0% | $26M | $1.4B | $98M |
| Sep '22 | $667M | $71M | 0.0% | 0.0% | -$35M | $1.4B | $93M |
| Jun '22 | $652M | $80M | 0.0% | 0.0% | $67M | $1.4B | $128M |
| Mar '22 | $617M | $61M | 0.0% | 0.0% | $26M | $1.5B | $140M |
| Dec '21 | $593M | $70M | 0.0% | 0.0% | $10M | $1.5B | $134M |
| Sep '21 | $588M | $66M | 0.0% | 0.0% | $66M | $1.4B | $196M |
| Jun '21 | $582M | $45M | 0.0% | 0.0% | $36M | $1.5B | $186M |
How the market has priced ACHC against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 5 years, Acadia Healthcare Company, Inc.'s revenue has grown 9.7% per year. These are computed facts, not advice.
As of FY2025, Acadia Healthcare Company, Inc. reported $2.5B of total debt against $133M of cash.
In FY2025, gross margin was —, operating margin —, and net margin -33.3%.
As of Jun '26, Acadia Healthcare Company, Inc. traded at a price-to-earnings ratio of about 6.1× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S have moved with the share price. These are computed facts, not advice.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.